10-Q 1 d52957e10vq.htm FORM 10-Q e10vq
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
     
þ   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended November 30, 2007
OR
     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission File No. 0-11488
PENFORD CORPORATION
(Exact name of registrant as specified in its charter)
     
Washington   91-1221360
     
(State or Other Jurisdiction of
Incorporation or Organization)
  (I.R.S. Employer
Identification No.)
     
7094 South Revere Parkway,
Centennial, Colorado
  80112-3932
     
(Address of Principal Executive Offices)   (Zip Code)
Registrant’s telephone number, including area code: (303) 649-1900
Indicate by a check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes þ     No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer o     Accelerated Filer þ     Non-Accelerated Filer o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o     No þ
The net number of shares of the Registrant’s common stock (the Registrant’s only outstanding class of stock) outstanding as of January 3, 2008 was 11,221,798.
 
 

 


 

PENFORD CORPORATION AND SUBSIDIARIES
INDEX
         
    Page  
       
 
       
       
 
       
    3  
 
       
    4  
 
       
    5  
 
       
    6  
 
       
    17  
 
       
    24  
 
       
    24  
 
       
       
 
       
    25  
 
       
    25  
 
       
    25  
 
       
    26  
 Certification of CEO Pursuant to Section 302
 Certification of CFO Pursuant to Section 302
 Certifications of CEO and CFO Pursuant to Section 1350

2


Table of Contents

PART I — FINANCIAL INFORMATION
Item 1: Financial Statements
PENFORD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
                 
    November 30,     August 31,  
(In thousands, except per share data)   2007     2007  
    (Unaudited)          
ASSETS
Current assets:
               
Cash
  $ 2,048     $  
Trade accounts receivable, net
    53,212       54,333  
Inventories
    38,123       39,537  
Prepaid expenses
    4,731       5,025  
Other
    5,419       6,384  
 
           
Total current assets
    103,533       105,279  
 
               
Property, plant and equipment, net
    163,596       146,663  
Restricted cash value of life insurance
    10,396       10,366  
Goodwill, net
    25,244       23,477  
Other intangible assets, net
    864       878  
Other assets
    1,871       1,725  
 
           
Total assets
  $ 305,504     $ 288,388  
 
           
 
               
LIABILITIES AND SHAREHOLDERS’ EQUITY
 
               
Current liabilities:
               
Cash overdraft, net
  $ 4,490     $ 5,468  
Current portion of long-term debt and capital lease obligations
    4,072       4,056  
Short-term borrowings
    4,040       7,218  
Accounts payable
    35,186       32,410  
Accrued liabilities
    14,797       17,094  
Total current liabilities
    62,585       66,246  
 
           
 
               
Long-term debt and capital lease obligations
    75,287       63,403  
Other post-retirement benefits
    12,935       12,814  
Deferred income taxes
    2,821       3,140  
Other liabilities
    17,756       17,109  
 
           
Total liabilities
    171,384       162,712  
 
               
Shareholders’ equity:
               
Preferred stock, par value $1.00 per share, authorized 1,000 shares, none issued
           
Common stock, par value $1.00 per share, authorized 29,000 shares, issued 11,102 and 11,099 shares, respectively
    11,102       11,099  
Additional paid-in capital
    44,320       43,902  
Retained earnings
    91,977       89,486  
Treasury stock, at cost, 1,981 shares
    (32,757 )     (32,757 )
Accumulated other comprehensive income
    19,478       13,946  
 
           
Total shareholders’ equity
    134,120       125,676  
 
           
Total liabilities and shareholders’ equity
  $ 305,504     $ 288,388  
 
           
The accompanying notes are an integral part of these statements.

3


Table of Contents

PENFORD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
                 
    Three months ended  
    November 30,     November 30,  
(In thousands, except per share data)   2007     2006  
 
               
Sales
  $ 94,861     $ 85,500  
 
               
Cost of sales
    78,608       72,306  
 
           
Gross margin
    16,253       13,194  
 
               
Operating expenses
    7,240       7,100  
Research and development expenses
    2,022       1,571  
Restructuring costs
    1,235        
 
           
 
               
Income from operations
    5,756       4,523  
 
               
Non-operating income, net
    464       521  
Interest expense
    1,266       1,304  
 
           
 
               
Income before income taxes
    4,954       3,740  
 
               
Income tax expense
    1,792       1,167  
 
           
 
               
Net income
  $ 3,162     $ 2,573  
 
           
 
               
Weighted average common shares and equivalents outstanding:
               
Basic
    9,118       8,944  
Diluted
    9,549       9,072  
 
               
Earnings per share:
               
Basic
  $ 0.35     $ 0.29  
Diluted
  $ 0.33     $ 0.28  
 
               
Dividends declared per common share
  $ 0.06     $ 0.06  
The accompanying notes are an integral part of these statements.

4


Table of Contents

PENFORD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(Unaudited)
                 
    Three Months Ended  
    November 30,     November 30,  
(In thousands)   2007     2006  
 
               
Cash flows from operating activities:
               
Net income
  $ 3,162     $ 2,573  
Adjustments to reconcile net income to net cash provided by (used in) operations:
               
Depreciation and amortization
    3,908       3,843  
Stock-based compensation
    362       299  
Deferred income taxes
    (374 )     (463 )
Loss on derivative transactions
    801       1,115  
Other
    (20 )     (26 )
Change in assets and liabilities:
               
Trade accounts receivable
    2,450       (3,535 )
Prepaid expenses
    366       385  
Inventories
    3,521       (3,992 )
Accounts payable and accrued liabilities
    (2,311 )     (4,486 )
Taxes payable
    1,426       1,231  
Other
    368       115  
 
           
 
               
Net cash provided by (used in) operating activities
    13,659       (2,941 )
 
           
 
               
Cash flows from investing activities:
               
Investment in property, plant and equipment, net
    (17,411 )     (7,430 )
Other
    (30 )     (33 )
 
           
 
               
Net cash used in investing activities
    (17,441 )     (7,463 )
 
           
 
               
Cash flows from financing activities:
               
Proceeds from short-term borrowings
    1,340       3,892  
Payments on short-term borrowings
    (5,091 )     (3,879 )
Proceeds from revolving line of credit
    13,774       12,989  
Payments on revolving line of credit
    (1,500 )     (8,820 )
Proceeds from long-term debt
          4,200  
Payments of long-term debt
    (1,000 )     (1,248 )
Payments under capital lease obligation
    (17 )     (12 )
Exercise of stock options
    47       319  
Payment of loan fees
          (805 )
Increase (decrease) in cash overdraft
    (978 )     3,178  
Payment of dividends
    (547 )     (536 )
Other
    (103 )     27  
 
           
 
               
Net cash provided by financing activities
    5,925       9,305  
 
           
 
               
Effect of exchange rate changes on cash and cash equivalents
    (95 )     160  
 
           
 
               
Net increase (decrease) in cash and cash equivalents
    2,048       (939 )
Cash and cash equivalents, beginning of period
          939  
 
           
Cash and cash equivalents, end of period
  $ 2,048     $  
 
           
The accompanying notes are an integral part of these statements.

5


Table of Contents

PENFORD CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
      1—BUSINESS
     Penford Corporation (which, together with its subsidiary companies, is referred to herein as “Penford” or the “Company”) is a developer, manufacturer and marketer of specialty natural-based ingredient systems for many industrial and food ingredient applications. The Company operates manufacturing facilities in the United States, Australia and New Zealand.
     Penford operates in three business segments, each utilizing its carbohydrate chemistry expertise to develop starch-based ingredients for value-added applications in several markets that improve the quality and performance of customers’ products, including papermaking and food products. The first two, industrial ingredients and food ingredients, are broad categories of end-market users, primarily served by the Company’s United States operations. The third segment consists of geographically separate operations in Australia and New Zealand. The Australian and New Zealand operations are engaged primarily in the food ingredients business.
     The Company has extensive research and development capabilities, which are used in understanding the complex chemistry of carbohydrate-based materials and in developing applications to address customer needs.
     Penford sells to a variety of customers and has several relatively large customers in each business segment. In fiscal 2007, the Company’s largest customer, Domtar, Inc., represented approximately 12% of consolidated net sales. For the three months ended November 30, 2007, Domtar, Inc. represented approximately 11% of consolidated net sales. Domtar, Inc. is a customer of the Company’s Industrial Ingredients—North America business.
     In June 2006, the Company announced plans to add ethanol production capability to its Cedar Rapids, Iowa facility. In October 2006, Penford refinanced its credit facility and obtained a $45 million capital expansion loan commitment maturing December 2012 to finance construction of the ethanol plant. The current designed capacity is up to 45 million gallons with construction cost estimates at $1.00 to $1.05 per gallon. Contracts valued at approximately $41 million have been awarded for this project as of the end of November 2007.
      2—BASIS OF PRESENTATION
     Consolidation
     The accompanying condensed consolidated financial statements include the accounts of Penford and its wholly owned subsidiaries. All material intercompany transactions and balances have been eliminated. The condensed consolidated balance sheet at November 30, 2007 and the condensed consolidated statements of operations and cash flows for the interim periods ended November 30, 2007 and 2006 have been prepared by the Company without audit. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, which are necessary to present fairly the financial information, have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles, have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The results of operations for interim periods are not necessarily indicative of the operating results of a full year or of future operations. Certain prior period amounts have been reclassified to conform with the current period presentation. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended August 31, 2007.
      Accounting Changes
     The Company adopted the provisions of Emerging Issues Task Force (“EITF”) Issue No. 06-2, “Accounting for Sabbatical Leave and Other Similar Benefits Pursuant to FASB Statement No. 43,” effective September 1, 2007. EITF Issue No. 06-2 requires companies to accrue the costs of compensated absences under a sabbatical or similar

6


Table of Contents

benefit arrangement over the requisite service period. Upon adoption, the Company recognized a $0.1 million charge to beginning retained earnings as a cumulative effect of a change in accounting principle.
     Effective September 1, 2007, the Company adopted FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement No. 109” (“FIN 48”), which clarifies the accounting for the uncertainty in income taxes recognized by prescribing a recognition threshold that a tax position is required to meet before being recognized in the financial statements. FIN 48 also provides guidance on derecognition, classification, interest and penalties, interim period accounting and disclosure. The impact of adopting FIN 48 is discussed in Note 7.
      Recent Accounting Pronouncements
     In September 2006, the FASB issued Statement No. 157, “Fair Value Measurements” (“SFAS 157”). SFAS 157 defines fair value, establishes a framework and gives guidance regarding the methods used for measuring fair value, and expands disclosures about fair value measurements. SFAS 157 is effective for fiscal years beginning after November 15, 2007 (fiscal 2009). The Company is evaluating the impact that adopting this statement may have on its consolidated financial statements.
     In February 2007, the FASB issued Statement No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities — including an amendment of FASB No. 115” (“SFAS 159”). SFAS 159 allows companies the option to measure financial instruments and certain other items at fair value that are not currently required to be measured at fair value. SFAS 159 is effective for fiscal years beginning after November 15, 2007 (fiscal 2009). The Company is currently evaluating the impact that the adoption of SFAS 159 may have on its consolidated financial statements.
      3—STOCK-BASED COMPENSATION
     Stock Compensation Plans
     Penford maintains the 2006 Long-Term Incentive Plan (the “2006 Incentive Plan”) pursuant to which various stock-based awards may be granted to employees, directors and consultants. Prior to the 2006 Incentive Plan, the Company awarded stock options to employees and officers through the Penford Corporation 1994 Stock Option Plan (the “1994 Plan”) and to members of its Board under the Stock Option Plan for Non-Employee Directors (the “Directors’ Plan”). The 1994 Plan was suspended when the 2006 Plan became effective. The Directors’ Plan expired in August 2005. As of November 30, 2007, the aggregate number of shares of the Company’s common stock that are available to be issued as awards under the 2006 Incentive Plan is 586,476. In addition, any shares previously granted under the 1994 Plan which are subsequently forfeited or not exercised will be available for future grants under the 2006 Incentive Plan.
      Valuation and Expense Under SFAS No. 123R
     On September 1, 2005, the Company adopted SFAS No. 123R which requires the measurement and recognition of compensation cost for all share-based payment awards made to employees and directors based on estimated fair values. The Company elected to use the modified prospective transition method for adopting SFAS No. 123R which requires the recognition of stock-based compensation cost on a prospective basis. Under this method, the provisions of SFAS No. 123R are applied to all awards granted after the adoption date and to awards not yet vested with unrecognized expense at the adoption date based on the estimated fair value at grant date as determined under the original provisions of SFAS No. 123.
     The Company utilizes the Black-Scholes option-pricing model to determine the fair value of stock options on the date of grant. This model derives the fair value of stock options based on certain assumptions related to expected stock price volatility, expected option life, risk-free interest rate and dividend yield. The Company’s expected volatility is based on the historical volatility of the Company’s stock price over the most recent period commensurate with the expected term of the stock option award. The estimated expected option life is based primarily on historical employee exercise patterns and considers whether and the extent to which the options are in-the-money. The risk-free interest rate assumption is based upon the U.S. Treasury yield curve appropriate for the term of the Company’s stock options awards and the selected dividend yield assumption was determined in view of

7


Table of Contents

the Company’s historical and estimated dividend payout. The Company has no reason to believe that the expected volatility of its stock price or its option exercise patterns would differ significantly from historical volatility or option exercises.
     No stock options were granted under the 2006 Incentive Plan during the three months ended November 30, 2007. For the three months ended November 30, 2006, the fair value of the options was estimated on the date of grant using the following assumptions.
         
Expected volatility
    45 %
Expected life (years)
    5.5  
Interest rate (percent)
    4.4-4.9  
Dividend yield
    1.5 %
 
       
Weighted-average fair values
  $ 6.74  
      Stock Option Awards
     A summary of the stock option activity for the three months ended November 30, 2007, is as follows:
                                 
                    Weighted    
            Weighted   Average    
    Number of   Average   Remaining   Aggregate Intrinsic
    Shares   Exercise Price   Term (in years)   Value
     
 
                               
Outstanding Balance, August 31, 2007
    1,033,977     $ 14.25                  
Granted
                           
Exercised
    (3,075 )     15.17                  
Cancelled
    (1,000 )     16.34                  
 
                               
Outstanding Balance, November 30, 2007
    1,029,902     $ 14.25       5.37     $ 10,247,400  
 
                               
Options Exercisable at November 30, 2007
    763,402     $ 13.77       5.06     $ 7,964,200  
     The aggregate intrinsic value disclosed in the table above represents the total pretax intrinsic value, based on the Company’s closing stock price of $24.20 as of November 30, 2007 that would have been received by the option holders had all option holders exercised on that date. The intrinsic value of options exercised during the three months ended November 30, 2007 and 2006 was $46,100 and $89,600, respectively.
     As of November 30, 2007, the Company had $0.8 million of unrecognized compensation costs related to non-vested stock option awards that is expected to be recognized over a weighted average period of 1.4 years.
     The following table summarizes information concerning outstanding and exercisable options as of November 30, 2007:
                                         
    Options Outstanding   Options Exercisable
            Wtd. Avg. Remaining   Wtd. Avg.           Wtd. Avg.
            Contractual Life   Exercise   Number of   Exercise
Range of Exercise Prices   Number of Options   (years)   Price   Options   Price
 
 
                                       
$7.59 — 13.00
    397,307       4.58     $ 12.01       397,307     $ 12.01  
13.01 — 16.00
    339,920       5.94       14.71       176,420       14.42  
16.01 — 19.77
    292,675       5.78       16.75       189,675       16.84  
 
                                       
 
    1,029,902                       763,402          
 
                                       

8


Table of Contents

      Restricted Stock Awards
     The grant date fair value of the Company’s restricted stock awards is equal to the fair value of Penford’s common stock at the grant date. The following table summarizes the restricted stock award activity for the three months ended November, 30, 2007 as follows:
                 
            Weighted
            Average
    Number of   Grant Date
    Shares   Fair Value
     
Nonvested at August 31, 2007
    5,796     $ 14.50  
Granted
    101,000       35.18  
Vested
    (2,898 )     14.50  
Cancelled
           
 
               
Nonvested at November 30, 2007
    103,898     $ 34.60  
     No restricted stock awards were granted under the 2006 Incentive Plan during the three months ended November 30, 2006.
     Non-employee directors received restricted stock under the 1993 Non-Employee Director Restricted Stock Plan, which provided that beginning September 1, 1993 and every three years thereafter, each non-employee director shall receive $18,000 worth of common stock of the Company, based on the last reported sale price of the stock on the preceding trading day. One-third of the shares vest on each anniversary of the date of the award. The Company recognizes compensation cost for restricted stock ratably over the vesting period. In September 2005, 8,694 shares of restricted common stock of the Company were granted to the non-employee directors. As of October 30, 2007, this plan has been terminated and no additional restricted stock will be granted under this plan.
     As of November 30, 2007, the Company had $3.4 million of unrecognized compensation costs related to non-vested restricted stock awards that is expected to be recognized over a weighted average period of 1.7 years.
      Compensation Expense
     The Company recognizes stock-based compensation expense utilizing the accelerated multiple option approach over the requisite service period, which equals the vesting period. The following table summarizes the total stock-based compensation cost under SFAS No. 123R for the three months ended November 30, 2007 and 2006 and the effect on the Company’s Condensed Consolidated Statements of Operations (in thousands):
                 
    Three Months Ended November 30,
    2007   2006
     
Cost of sales
  $ 37     $ 24  
Operating expenses
    320       268  
Research and development expenses
    5       7  
     
Total stock-based compensation expense
  $ 362     $ 299  
Tax benefit
    138       114  
     
Total stock-based compensation expense, net of tax
  $ 224     $ 185  
     
     See Note 12 for stock-based compensation costs recognized in the financial statements of each business segment.

9


Table of Contents

      4—INVENTORIES
     The components of inventory are as follows:
                 
    November 30,     August 31,  
    2007     2007  
    (In thousands)  
Raw materials
  $ 15,501     $ 17,438  
Work in progress
    726       720  
Finished goods
    21,896       21,379  
 
           
Total inventories
  $ 38,123     $ 39,537  
 
           
      5—PROPERTY, PLANT AND EQUIPMENT
     The components of property, plant and equipment are as follows:
                 
    November 30,     August 31,  
    2007     2007  
    (In thousands)  
Land
  $ 18,676     $ 17,694  
Plant and equipment
    346,358       338,496  
Construction in progress
    41,730       27,433  
 
           
 
    406,764       383,623  
Accumulated depreciation
    (243,168 )     (236,960 )
 
           
Net property, plant and equipment
  $ 163,596     $ 146,663  
 
           
     Changes in Australian and New Zealand currency exchange rates have increased net property, plant and equipment in the first quarter of fiscal 2008 by approximately $3.2 million.
     For the first three months of fiscal 2008, the Company had $12.7 million of capital expenditures related to construction of the ethanol facility. As of November 30, 2007, the Company had a total of $32.7 million in capital expenditures related to the ethanol facility which includes $0.7 million in related capitalized interest costs.
      6—DEBT
     On October 5, 2006, the Company entered into a $145 million Second Amended and Restated Credit Agreement (the “2007 Agreement”) among the Company; Harris N.A.; LaSalle Bank National Association; Cooperative Centrale Raiffeisen-Boorleenbank B.A., “Rabobank Nederland” (New York Branch); U.S. Bank National Association; and the Australia and New Zealand Banking Group Limited.
     The 2007 Agreement refinanced the Company’s previous $105 million secured term and revolving credit facilities. Under the 2007 Agreement, the Company may borrow $40 million in term loans and $60 million in revolving lines of credit. The lenders’ revolving credit loan commitment may be increased under certain conditions. In addition, the 2007 Agreement provided the Company with $45 million in capital expansion funds which may be used by the Company to finance the construction of its ethanol production facility in Cedar Rapids, Iowa. The capital expansion funds may be borrowed as term loans from time to time prior to October 5, 2008.
     The final maturity date for the term and revolving loans under the 2007 Agreement is December 31, 2011. Beginning on December 31, 2006, the Company must repay the term loans in twenty equal quarterly installments of $1.0 million, with the remaining amount due at final maturity. The final maturity date for the capital expansion loans is December 31, 2012. Beginning on December 31, 2008, the Company must repay the capital expansion loans in equal quarterly installments of $1.25 million through September 30, 2009 and $2.5 million thereafter, with the remaining amount due at final maturity. Interest rates under the 2007 Agreement are based on either the London Interbank Offering Rates (“LIBOR”) in Australia or the United States, or the prime rate, depending on the selection of available borrowing options under the 2007 Agreement.

10


Table of Contents

     The Agreement provides that the Total Funded Debt Ratio, which is computed as funded debt divided by earnings before interest, taxes, depreciation and amortization (as defined in the 2007 Agreement) shall not exceed 4.50 through August 31, 2008. Subsequent to August 31, 2008, the maximum Total Funded Debt Ratio varies between 3.00 and 4.25. In addition, the Company must maintain a minimum tangible net worth of $65 million, and a Fixed Charge Coverage Ratio, as defined in the 2007 Agreement, of not less than 1.25 in fiscal 2008 and 1.50 in fiscal 2009 and thereafter. Annual capital expenditures, exclusive of capital expenditures incurred in connection with the Company’s ethanol production facility, are limited to $20 million, unless the Company can maintain a Total Funded Debt Ratio below 2.00 for each fiscal quarter during any fiscal year, which would result in the annual capital expenditure limit to increase to $25 million for such fiscal year. The Company’s obligations under the 2007 Agreement are secured by substantially all of the Company’s U.S. assets.
     At November 30, 2007, the Company had $21.2 million and $36.0 million outstanding, respectively, under the revolving credit and term loan portions of its credit facility. In addition, the Company had borrowed $22.0 million of the $45 million in capital expansion loans available under the credit facility for the construction of the ethanol facility. Pursuant to the terms of the 2007 Agreement, Penford’s additional borrowing ability as of November 30, 2007 was $23.0 million under the capital expansion facility and $38.8 million under the revolving credit facility. The Company was in compliance with the covenants in the Agreement as of November 30, 2007 and expects to be in compliance with the covenants for the remainder of fiscal 2008.
     The Company’s short-term borrowings consist of an Australian variable-rate revolving grain inventory financing facility with an Australian bank for a maximum of $35.2 million U.S. dollars at the exchange rate at November 30, 2007. The amount outstanding under this arrangement, which is classified as a current liability on the balance sheet, was $4.0 million at November 30, 2007.
     As of November 30, 2007, all of the Company’s outstanding debt, including amounts outstanding under the Australian grain inventory financing facility, is subject to variable interest rates. Under interest rate swap agreements with several banks, the Company has fixed its interest rates on U.S. dollar denominated debt of $31.6 million at 4.18% and $4.4 million at 5.08%, plus the applicable margin under the Company’s credit agreement. At November 30, 2007, the fair value of the interest rate swaps was recorded in the balance sheet as a liability of $0.5 million.
     In December 2007, the Company completed a common stock offering resulting in the issuance of 2,000,000 additional common shares at a price of $25.00 per share. The Company received approximately $47.2 million of net proceeds (net of $2.8 million of expenses related to the offering) from the sale of 2,000,000 shares. The proceeds were used to reduce the Company’s outstanding debt. See Note 15.
      7—INCOME TAXES
     FIN 48
     On September 1, 2007, the Company adopted FIN 48. FIN 48 prescribes a recognition threshold that a tax position is required to meet before being recognized in the financial statements and provides guidance on de-recognition, measurement, classification, interest and penalties and transition issues. FIN 48 contains a two-step process for recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the available evidence indicates that it is more likely than not that the position will be sustained on audit, including related appeals or litigation. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate settlement.
     As a result of the implementation of FIN 48 on September 1, 2007, Penford reclassified $0.9 million of previously recorded tax reserves from a current income tax liability to a long-term liability for unrecognized tax benefits. The Company reclassified unrecognized tax benefits for which it does not anticipate the payment or receipt of cash within one year. The Company historically classified unrecognized tax benefits in current income taxes payable. There was no change in retained earnings resulting from the adoption of FIN 48. The Company’s policy is to recognize interest and penalty expense associated with uncertain tax positions as a component of income tax expense in the consolidated statements of operations. As of September 1, 2007, the Company had $0.2 million of accrued interest and penalties included in the long-term tax liability.

11


Table of Contents

     At September 1, 2007, the liability for unrecognized tax benefits was $0.9 million, all of which would affect the effective tax rate if realized. During the first quarter of fiscal 2008, the Company increased its liability for unrecognized tax benefits and increased its income tax expense by $56,000.
     The Company files tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions and is subject to examination by taxing authorities in all of those jurisdictions. The Company is currently under audit by the income taxing authorities in one U.S. state for fiscal years 2003 through 2005. This audit may conclude in the next twelve months and the unrecognized tax benefits recorded for this audit may change compared to the liabilities recorded at November 30, 2007. While the Company cannot estimate the effect, if any, of such change during the next twelve months to previously recorded uncertain tax positions, it does not believe such change would be material to the Company’s consolidated results of operations or financial position. With few exceptions, the Company is not subject to income tax examinations by federal, state or foreign jurisdictions for fiscal years prior to 2001.
      Effective Tax Rate
     The Company’s effective tax rate, which included an increase in the Company’s long-term tax liability, for the three months ended November 30, 2007 was 36%, an increase from the 31% effective tax rate in the first quarter of fiscal 2007, primarily due to an increase in the Company’s estimated pre-tax income for fiscal 2008 compared to the prior year.
     On a quarterly basis, the Company reviews its estimate of the effective income tax rate expected to be applicable for the full fiscal year. This rate is used to calculate income tax expense or benefit on current year-to-date pre-tax income or loss. Income tax expense or benefit for the current interim period is the difference between the computed year-to-date income tax amount and the tax expense or benefit reported for previous quarters. In reviewing its effective tax rate, the Company uses estimates of the amounts of permanent differences between book and tax accounting and projections of fiscal year pre-tax income or loss.
      8—OTHER COMPREHENSIVE INCOME
     The components of total comprehensive income are as follows:
                 
    Three months ended  
    November 30,     November 30,  
    2007     2006  
    (In thousands)  
 
               
Net income
  $ 3,162     $ 2,573  
Foreign currency translation adjustments
    5,471       1,938  
Change in unrealized gains on derivative instruments that qualify as cash flow hedges, net of tax
    61       (1,068 )
 
           
Total comprehensive income
  $ 8,694     $ 3,443  
 
           
      9—NON-OPERATING INCOME, NET
     Non-operating income, net consists of the following:
                 
    Three months ended  
    November 30,     November 30,  
    2007     2006  
    (In thousands)  
 
               
Royalty and licensing income
  $ 451     $ 518  
Other
    13       3  
 
           
Total
  $ 464     $ 521  
 
           

12


Table of Contents

     In fiscal 2003, the Company exclusively licensed to National Starch and Chemical Investment Holdings Corporation (“National Starch”) certain rights to its resistant starch patent portfolio (the “RS Patents”) for applications in human nutrition. Under the terms of the licensing agreement, the Company received an initial licensing fee of $2.25 million ($1.6 million net of transaction expenses) which is being amortized over the life of the royalty agreement. The Company has recognized $9.0 million in royalty income from the inception of the agreement through November 30, 2007.
     In the first quarter of fiscal 2007, in connection with the settlement of litigation in which Penford’s Australian subsidiary companies were plaintiffs, Penford received a one-time payment of $625,000 and granted a license to one of the defendants in this litigation under Penford’s RS Patents in certain non-human nutrition applications. In addition, Penford became entitled to receive additional royalties under a license of rights under the RS Patents in human nutrition applications granted to one of the defendants. As part of the settlement agreement, Penford became entitled to receive certain other benefits, including an acceleration and extension of certain royalties under its license with National Starch. The Company is deferring and recognizing license income of $625,000 ratably over the remaining life of the patent license, which is estimated to be seven years.
      10 — PENSION AND POST-RETIREMENT BENEFIT PLANS
     The components of the net periodic pension and post-retirement benefit costs for the three months ended November 30, 2007 and 2006 are as follows:
     Defined benefit pension plans
                 
    Three months ended  
    November 30,     November 30,  
    2007     2006  
 
               
Service cost
  $ 371     $ 388  
Interest cost
    623       584  
Expected return on plan assets
    (663 )     (593 )
Amortization of prior service cost
    63       46  
Amortization of actuarial losses
    13       48  
 
           
Net periodic benefit cost
  $ 407     $ 473  
 
           
     Post-retirement health care plans
                 
    Three months ended  
    November 30,     November 30,  
    2007     2006  
 
               
Service cost
  $ 78     $ 77  
Interest cost
    213       205  
Amortization of prior service cost
    (38 )     (38 )
 
           
Net periodic benefit cost
  $ 253     $ 244  
 
           
     Effective August 1, 2004, the Company’s post-retirement health care benefit plan covering bargaining unit hourly employees was closed to new entrants and to any current employee who did not meet minimum requirements as to age plus years of service. The defined benefit pension plans for salary and hourly employees were closed to new participants effective January 1, 2005 and August 1, 2004, respectively.
      11—RESTRUCTURING COSTS
     In the first quarter of fiscal 2008, in connection with reconfiguring the Company’s Australian business, a workforce reduction was implemented in the two Australian operating facilities. In connection therewith, $1.2 million in employee severance costs and related benefits were charged to operating income in the first quarter and are shown as restructuring costs in the condensed consolidated statement of operations. The restructure reserve at November 30, 2007 of $0.7 million represents remaining severance and related benefits which were paid in December 2007.

13


Table of Contents

     12—SEGMENT REPORTING
     Financial information for the Company’s three segments is presented below. The first two segments, Industrial Ingredients—North America and Food Ingredients—North America, are broad categories of end-market users, primarily served by the Company’s U.S. operations. The Industrial Ingredients segment provides carbohydrate-based starches for industrial applications, primarily in the paper and packaging products industries. The Food Ingredients segment produces specialty starches for food applications. The third segment is the Company’s geographically separate operations in Australia and New Zealand, which are engaged primarily in the food ingredients business. A fourth item for “corporate and other” activity is presented to provide reconciliation to amounts reported in the condensed consolidated financial statements. Corporate and other represents the activities related to the corporate headquarters such as public company reporting, personnel costs of the executive management team, corporate-wide professional services and elimination and consolidation entries. The elimination of intercompany sales between Australia/New Zealand operations and Food Ingredients—North America is presented separately since the chief operating decision maker views segment results prior to intercompany eliminations.
                 
    Three months ended  
    November 30,     November 30,  
    2007     2006  
    (In thousands)  
Sales:
               
Industrial Ingredients—North America
  $ 49,209     $ 43,972  
Food Ingredients—North America
    16,076       15,240  
Australia/New Zealand operations
    29,944       26,524  
Intercompany sales
    (368 )     (236 )
 
           
 
  $ 94,861     $ 85,500  
 
           
 
               
Income (loss) from operations:
               
Industrial Ingredients—North America
  $ 5,696     $ 3,182  
Food Ingredients—North America
    2,652       2,853  
Australia/New Zealand operations
    (75 )     808  
Corporate and other
    (2,517 )     (2,320 )
 
           
 
  $ 5,756     $ 4,523  
 
           
                 
    November 30,     August 31,  
    2007     2007  
     
    (In thousands)  
Total assets:
               
Industrial Ingredients—North America
  $ 143,222     $ 133,187  
Food Ingredients—North America
    33,441       33,684  
Australia/New Zealand operations
    116,174       108,084  
Corporate and other
    12,667       13,433  
 
           
 
  $ 305,504     $ 288,388  
 
           

14


Table of Contents

     The following table summarizes the stock-based compensation expense related to stock option and restricted stock awards by segment for the three months ended November 30, 2007 and 2006.
                 
    Three months ended
    November 30, 2007   November 30, 2006
     
    (In thousands)
 
               
Industrial Ingredients—North America
  $ 88     $ 68  
Food Ingredients—North America
    56       43  
Australia/New Zealand operations
    10       20  
Corporate
    208       168  
     
 
  $ 362     $ 299  
     
     13—EARNINGS PER SHARE
     Basic earnings per share reflect only the weighted average common shares outstanding during the period. Diluted earnings per share reflect weighted average common shares outstanding and the effect of any dilutive common stock equivalent shares. Diluted earnings per share is calculated by dividing net income by the average common shares outstanding plus additional common shares that would have been outstanding assuming the exercise of in-the-money stock options, using the treasury stock method. The following table presents the computation of diluted weighted average shares outstanding for the three months ended November 30, 2007 and 2006.
                 
    Three months ended
    November 30, 2007   November 30, 2006
    (In thousands)
Weighted average common shares outstanding
    9,118       8,944  
Dilutive stock options and awards
    431       128  
 
               
Weighted average common shares outstanding, assuming dilution
    9,549       9,072  
 
               
     Weighted-average stock options to purchase 434,571 shares of common stock for the three months ended November 30, 2006 were excluded from the calculation of diluted earnings per share because they were antidilutive. For the three months ended November 30, 2007, there were no stock options or awards excluded from the calculation of diluted earnings per share.
     14—LEGAL PROCEEDINGS
     In October 2004, Penford Products Co. (“Penford Products”), a wholly-owned subsidiary of the Company, was sued by Graphic Packaging International, Inc. (“Graphic”) in the Fourth Judicial District Court, Ouachita Parish, Louisiana. Graphic sought monetary damages for Penford Products’ alleged breach of an agreement during the 2004 strike affecting its Cedar Rapids, Iowa plant to supply Graphic with certain starch products. Penford Products denied all liability and countersued for damages.
     During October 2007, this case was tried before a judge of the above-noted court. As of January 8, 2008, the court had not advised Penford Products of a decision in the matter or the date upon which a decision would be rendered. At trial, Graphic argued that it was entitled to damages in the amount of approximately $3.27 million, plus interest. Penford Products argued that it was entitled to damages of approximately $550,000, plus interest.
     While the Company vigorously defended its position at trial, it has, after applying its best judgment regarding the likely outcome of the litigation, established a loss contingency against this matter of $2.4 million. Depending upon the eventual outcome of this litigation, the Company may incur additional material charges in excess of the amount it has reserved, or it may incur lower charges, the amounts of which in each case management is unable to predict at this time.

15


Table of Contents

     The Company is involved from time to time in various other claims and litigation arising in the normal course of business. In the judgment of management, which relies in part on information from the Company’s outside legal counsel, the ultimate resolution of these matters will not materially affect the consolidated financial position, results of operations or liquidity of the Company.
     15—SUBSEQUENT EVENT
     In December 2007, the Company completed a common stock offering resulting in the issuance of 2,000,000 additional common shares at a price of $25.00 per share. The Company received approximately $47.2 million of net proceeds (net of $2.8 million of expenses related to the offering) from the sale of 2,000,000 shares. The proceeds were used to reduce the Company’s outstanding debt. Pursuant to the terms of the Company’s credit facility agreement, half of the net proceeds, $23.6 million, were used to repay amounts outstanding under the term loan portion of the Company’s credit facility. The remaining net proceeds were used to repay $22.8 million and $0.8 million, respectively, of amounts due under the revolving credit and capital expansion loan portions of the credit facility.

16


Table of Contents

     Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward-looking Statements
     The statements contained in this Quarterly Report on Form 10-Q (“Quarterly Report”) that are not historical facts, including, but not limited to statements found in the Notes to Condensed Consolidated Financial Statements and in this Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations, are forward-looking statements that represent management’s beliefs and assumptions based on currently available information. Forward-looking statements can be identified by the use of words such as “believes,” “may,” “will,” “looks,” “should,” “could,” “anticipates,” “expects,” or comparable terminology or by discussions of strategies or trends.
     Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it cannot give any assurances that these expectations will prove to be correct. Such statements by their nature involve substantial risks and uncertainties that could significantly affect expected results. Actual future results could differ materially from those described in such forward-looking statements, and the Company does not intend to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that could cause actual results to differ materially are the risks and uncertainties discussed in this Quarterly Report, including those referenced in Item 1A in this Quarterly Report, and those described from time to time in other filings with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the year ended August 31, 2007, which include, but are not limited to:
    competition;
 
    the possibility of interruption of business activities due to equipment problems, accidents, strikes, weather or other factors;
 
    product development risk;
 
    changes in corn and other raw material prices and availability;
 
    expectations regarding the construction cost of the ethanol facility and the timing of ethanol production;
 
    changes in general economic conditions or developments with respect to specific industries or customers affecting demand for the Company’s products including unfavorable shifts in product mix;
 
    unanticipated costs, expenses or third-party claims;
 
    the risk that results may be affected by construction delays, cost overruns, technical difficulties, nonperformance by contractors or changes in capital improvement project requirements or specifications;
 
    interest rate, chemical and energy cost volatility;
 
    foreign currency exchange rate fluctuations;
 
    changes in assumptions used for determining employee benefit expense and obligations; or
 
    other unforeseen developments in the industries in which Penford operates.

17


Table of Contents

Overview
     Penford generates revenues, income and cash flows by developing, manufacturing and marketing specialty natural-based ingredient systems for industrial and food applications. The Company develops and manufactures ingredients with starch as a base, providing value-added applications to its customers. Penford’s starch products are manufactured primarily from corn, potatoes, and wheat and are used principally as binders and coatings in paper and food production.
     In analyzing business trends, management considers a variety of performance and financial measures, including sales revenue growth, sales volume growth, and gross margins and operating income of the Company’s business segments. Penford manages its business in three segments. The first two, Industrial Ingredients—North America and Food Ingredients—North America, are broad categories of end-market users, served by operations in the United States. The third segment is comprised of the Company’s operations in Australia and New Zealand, which operations are engaged primarily in the food ingredients business. See Notes 1 and 12 to the Condensed Consolidated Financial Statements for additional information regarding the Company’s business segment operations.
     Accounting Changes
     The Company adopted the provisions of Emerging Issues Task Force (“EITF”) Issue No. 06-2, “Accounting for Sabbatical Leave and Other Similar Benefits Pursuant to FASB Statement No. 43,” effective September 1, 2007. EITF Issue No. 06-2 requires companies to accrue the costs of compensated absences under a sabbatical or similar benefit arrangement over the requisite service period. Upon adoption, the Company recognized a $0.1 million charge to beginning retained earnings as a cumulative effect of a change in accounting principle.
     Effective September 1, 2007, the Company adopted FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement No. 109” (“FIN 48”), which clarifies the accounting for the uncertainty in income taxes recognized by prescribing a recognition threshold that a tax position is required to meet before being recognized in the financial statements. FIN 48 also provides guidance on derecognition, classification, interest and penalties, interim period accounting and disclosure. The impact of adopting FIN 48 is discussed in Note 7 to the Condensed Consolidated Financial Statements.
Results of Operations
     Executive Overview
     Consolidated sales for the three months ended November 30, 2007 increased 11% to $94.9 million from $85.5 million in the first quarter of fiscal 2007, primarily due to improved unit pricing and favorable product mix, which contributed approximately $9.4 million, the pass-through impact on sales of higher corn costs in the Industrial Ingredients business which added $2.8 million to total sales, and favorable foreign currency exchange rates of $4.0 million, partially offset by a decline in sales volume. Gross margin as a percent of sales expanded to 17.1%, 170 basis points above the same period last year of 15.4%, primarily driven by revenue gains, and partially offset by higher raw material costs for corn and wheat at the Company’s Australian business caused by continuing drought conditions in the region. Income from operations increased to $5.8 million, a $1.2 million increase over the first quarter of fiscal 2007 due to gross margin improvements. Research and development expenses increased by $0.5 million on additional headcount and new product activity. Operating income for the first quarter of fiscal 2008 included $1.2 million of severance costs related to reconfiguring the Australia/New Zealand business. See Note 11 to the Condensed Consolidated Financial Statements. A discussion of segment results of operations and the effective tax rate follows.

18


Table of Contents

     Sales
     Sales during the first quarter of fiscal 2008 for the Company’s Industrial Ingredients—North America business unit were $49.2 million, a $5.2 million, or 12%, increase compared to the same period last year. Increases in average unit selling prices and improved product mix contributed $5.2 million to the sales growth, and the “pass through” impact from higher corn prices added another $2.8 million to total sales, partially offset by a 6% decline in volume attributable to customer mill closures designed to optimize operating rates and inventory levels.
     Penford sells to a variety of customers and has several relatively large customers in each business segment. For fiscal 2007, the Company’s largest customer, Domtar, Inc., represented approximately 12% of consolidated net sales. For the three months ended November 30, 2007, Domtar, Inc. represented approximately 11% of consolidated net sales. Domtar, Inc. is a customer of the Company’s Industrial Ingredients—North America business.
     Food Ingredients—North America sales for the first quarter of fiscal 2008 expanded 6% or $0.8 million over the same period in fiscal 2007 due to improved average unit selling prices and favorable product mix, partially offset by volume decline of 8%, primarily due to a reduction in sales of unmodified starches.
     First quarter fiscal 2008 sales for the Australia/New Zealand operations increased 13% to $29.9 million from $26.5 million in the same period of fiscal 2007. Higher average unit pricing and product mix added $2.1 million to total sales and favorable foreign currency exchange rates contributed $4.0 million to sales growth. A volume decline of 10% due to product rationalization programs partially offset revenue expansion.
     Income from operations
     For the first quarter of fiscal 2008, income from operations at the Company’s Industrial Ingredients—North America business unit was $5.7 million, a $2.5 million increase over the same quarter last year. First quarter fiscal 2008 gross margin as a percent of sales grew 380 basis points to 17.4% from 13.6% for the first quarter of fiscal 2007 due to favorable unit pricing in all major product lines and improved product mix, partially offset by higher chemical and other production costs.
     Income from operations for the first quarter of fiscal 2008 at the Food Ingredients—North America was $2.7 million, a $0.2 million decline compared to the same quarter last year. Gross margin as a percent of sales declined to 28.3% from 31.4% last year due to higher raw material starch costs, lower volumes and increased maintenance, partially offset by improved pricing and product mix.
     First quarter fiscal 2008 loss from operations at the Company’s Australia/New Zealand operations was $0.1 million compared to $0.8 million income from operations for the three months ended November 30, 2006. Gross margin as a percent of sales improved to 10.5%, a 140 basis point increase over the first quarter of fiscal 2007, primarily due to favorable unit pricing and improved plant efficiency levels, partially offset by higher grains costs caused by drought conditions in Australia. Included in the segment’s operating loss for the first quarter of fiscal 2008 was a restructuring charge of $1.2 million. See Note 11 to the Condensed Consolidated Financial Statements.
     Corporate operating expenses
     Corporate operating expenses for the first quarter of fiscal 2008 rose to $2.5 million, a $0.2 million increase over the same period last year due to higher professional fees and employee related costs.
     Interest and taxes
     Interest expense for the first quarter of fiscal 2008 declined 3% due to lower average debt balances, excluding ethanol-related debt borrowings. Interest costs related to construction of the ethanol facility have been capitalized. The Company’s debt includes the amount outstanding under its grain inventory financing facility. See Note 6 to the Condensed Consolidated Financial Statements.
     Effective September 1, 2007, the Company adopted FIN 48. See Note 7 to the Condensed Consolidated Financial Statements for further discussion. The Company’s effective tax rate, which included an increase in the

19


Table of Contents

Company’s long-term tax liability, for the three months ended November 30, 2007 was 36%, an increase from the 31% effective tax rate in the first quarter of fiscal 2007, primarily due to an increase in the Company’s estimated pre-tax income for fiscal 2008 compared to the prior year.
     On a quarterly basis, the Company reviews its estimate of the effective income tax rate expected to be applicable for the full fiscal year. This rate is used to calculate income tax expense or benefit on current year-to-date pre-tax income or loss. Income tax expense or benefit for the current interim period is the difference between the computed year-to-date income tax amount and the tax expense or benefit reported for previous quarters. In reviewing its effective tax rate, the Company uses estimates of the amounts of permanent differences between book and tax accounting and projections of fiscal year pre-tax income or loss.
     The determination of the annual effective tax rate is based upon a number of estimates and judgments, including the estimated annual pretax income of the Company in each tax jurisdiction and the amounts of permanent differences between the book and tax accounting for various items. The Company’s interim tax expense can be impacted by changes in tax rates or laws, the finalization of tax audits and other items that cannot be estimated with any certainty. Therefore, there can be significant volatility in the interim provision for income tax expense.
     Non-operating income, net
     Non-operating income, net consists of the following:
                 
    Three months ended  
    November 30, 2007     November 30, 2006  
    (In thousands)  
 
               
Royalty and licensing income
  $ 451     $ 518  
Other
    13       3  
 
           
Total
  $ 464     $ 521  
 
           
     In fiscal 2003, the Company exclusively licensed to National Starch and Chemical Investment Holdings Corporation (“National Starch”) certain rights to its resistant starch patent portfolio (the “RS Patents”) for applications in human nutrition. Under the terms of the licensing agreement, the Company received an initial licensing fee of $2.25 million ($1.6 million net of transaction expenses) which is being amortized over the life of the royalty agreement. The Company has recognized $9.0 million in royalty income from the inception of the agreement through November 30, 2007.
     In the first quarter of fiscal 2007, in connection with the settlement of litigation in which Penford’s Australian subsidiary companies were plaintiffs, Penford received a one-time payment of $625,000 and granted a license to one of the defendants in this litigation under Penford’s RS Patents in certain non-human nutrition applications. In addition, Penford became entitled to receive additional royalties under a license of rights under the RS Patents in human nutrition applications granted to one of the defendants. As part of the settlement agreement, Penford became entitled to receive certain other benefits, including an acceleration and extension of certain royalties under its license with National Starch. The Company is deferring and recognizing license income of $625,000 ratably over the remaining life of the patent license, which is estimated to be seven years.
Liquidity and Capital Resources
     On October 5, 2006, the Company entered into a $145 million Second Amended and Restated Credit Agreement (the “2007 Agreement”). See Note 6 to the Condensed Consolidated Financial Statements.
     At November 30, 2007, the Company had $21.2 million and $36.0 million outstanding, respectively, under the revolving credit and term loan portions of its credit facility. In addition, the Company had borrowed $22.0 million of the $45 million in capital expansion loans available under the credit facility for the construction of the ethanol facility. Pursuant to the terms of the 2007 Agreement, Penford’s additional borrowing ability as of November 30, 2007 was $23.0 million under the capital expansion facility and $38.8 million under the revolving credit facility.

20


Table of Contents

The Company was in compliance with the covenants in the Agreement as of November 30, 2007 and expects to be in compliance with the covenants for the remainder of fiscal 2008.
     The Company’s short-term borrowings consist of an Australian variable-rate revolving grain inventory financing facility with an Australian bank for a maximum of $35.2 million U.S. dollars at the exchange rate at November 30, 2007. The amount outstanding under this arrangement, which is classified as a current liability on the balance sheet, was $4.0 million at November 30, 2007.
     As of November 30, 2007, all of the Company’s outstanding debt, including amounts outstanding under the Australian grain inventory financing facility, was subject to variable interest rates. Under interest rate swap agreements with several banks, the Company has fixed its interest rates on U.S. dollar denominated debt of $31.6 million at 4.18% and $4.4 million at 5.08%, plus the applicable margin under the Company’s credit agreement. At November 30, 2007, the fair value of the interest rate swaps was recorded in the balance sheet as a liability of $0.5 million.
     Penford had working capital of $40.9 million and $39.0 million at November 30, 2007 and August 31, 2007, respectively. Cash provided by operations was $13.7 million for the three months ended November 30, 2007 compared to cash used in operations of $2.9 million for the three months ended November 30, 2006. The increase in cash flow from operations is due to improved earnings over the prior year and impact of favorable working capital balances related to accounts receivable and inventory. Total debt outstanding, including the effects of stronger foreign currency exchange rates, increased $8.7 million during the first three months of fiscal 2008 primarily to fund $17 million in capital expenditures, including those to construct the ethanol facility. For the first quarter of fiscal 2008, the Company had $12.7 million of capital expenditures related to the ethanol facility. As of November 30, 2007, the Company had a total of $32.7 million in capital expenditures related to the ethanol facility which includes $0.7 million in related capitalized interest costs. Currently, the Company estimates its total capital expenditures in fiscal 2008 to be $47 million, including $27 million related to the ethanol facility.
     The Company paid dividends of $0.5 million during the three months ended November 30, 2007, which represents a quarterly rate of $0.06 per share. On October 30, 2007, the Board of Directors declared a dividend of $0.06 per common share payable on December 7, 2007 to shareholders of record as of November 16, 2007. Any future dividends will be paid at the discretion of the Company’s board of directors and will depend upon, among other things, earnings, financial condition, cash requirements and availability, and contractual requirements.
     In December 2007, the Company completed a common stock offering resulting in the issuance of 2,000,000 additional common shares at a price of $25.00 per share. The Company received approximately $47.2 million of net proceeds (net of $2.8 million of expenses related to the offering) from the sale of 2,000,000 shares and these proceeds were used to reduce the Company’s outstanding debt.
Contractual Obligations
     The Company is a party to various debt and lease agreements at November 30, 2007 that contractually commit the Company to pay certain amounts in the future. The Company also has open purchase orders entered into in the ordinary course of business for raw materials, capital projects and other items, for which significant terms have been confirmed. As of November 30, 2007, there have been no material changes in the Company’s contractual obligations since August 31, 2007.
     As discussed above, proceeds from the sale of common stock were used to reduce long-term debt contractual obligations by $47.2 million.
Off-Balance Sheet Arrangements
     The Company had no off-balance sheet arrangements at November 30, 2007.
Recent Accounting Pronouncements
     In September 2006, the FASB issued Statement No. 157, “Fair Value Measurements” (“SFAS 157”). SFAS 157 defines fair value, establishes a framework and gives guidance regarding the methods used for measuring fair value,

21


Table of Contents

and expands disclosures about fair value measurements. SFAS 157 is effective for fiscal years beginning after November 15, 2007 (fiscal 2009). The Company is evaluating the impact that adopting this statement may have on its consolidated financial statements.
     In February 2007, the FASB issued Statement No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities — including an amendment of FASB No. 115” (“SFAS 159”). SFAS 159 allows companies the option to measure financial instruments and certain other items at fair value that are not currently required to be measured at fair value. SFAS 159 is effective for fiscal years beginning after November 15, 2007 (fiscal 2009). The Company is currently evaluating the impact that the adoption of SFAS 159 may have on its consolidated financial statements.
Critical Accounting Policies
     The Company’s consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States. The process of preparing financial statements requires management to make estimates, judgments and assumptions that affect the Company’s financial position and results of operations. These estimates, judgments and assumptions are based on the Company’s historical experience and management’s knowledge and understanding of the current facts and circumstances. Note 1 to the Consolidated Financial Statements in the Annual Report on Form 10-K for the fiscal year ended August 31, 2007 describes the significant accounting policies and methods used in the preparation of the consolidated financial statements. Management believes that its estimates, judgments and assumptions are reasonable based upon information available at the time this report was prepared. To the extent there are material differences between estimates, judgments and assumptions and the actual results, the financial statements will be affected.
     Management has reviewed the accounting policies and related disclosures with the Audit Committee of the Board of Directors. The accounting policies that management believes are the most important to the financial statements and that require the most difficult, subjective and complex judgments include the following:
    Evaluation of the allowance for doubtful accounts receivable
 
    Hedging activities
 
    Benefit plans
 
    Valuation of goodwill
 
    Self-insurance program
 
    Income taxes
 
    Stock-based compensation
     A description of each of these follows:
     Evaluation of the Allowance for Doubtful Accounts Receivable
     Management makes judgments about the Company’s ability to collect outstanding receivables and provides allowances for the portion of receivables that the Company may not be able to collect. Penford estimates the allowance for uncollectible accounts based on historical experience, known troubled accounts, industry trends, economic conditions, how recently payments have been received, and ongoing credit evaluations of its customers. If the estimates do not reflect the Company’s future ability to collect outstanding invoices, Penford may experience losses in excess of the reserves established. At November 30, 2007, the allowance for doubtful accounts receivable was $0.6 million.

22


Table of Contents

     Hedging Activities
     Penford uses derivative instruments, primarily futures contracts, to reduce exposure to price fluctuations of commodities used in the manufacturing processes in the United States. Penford has elected to designate these activities as hedges. This election allows the Company to defer gains and losses on those derivative instruments until the underlying commodity is used in the production process. To reduce exposure to variable short-term interest rates, Penford uses interest rate swap agreements.
     The requirements for the designation of hedges are very complex, and require judgments and analyses to qualify as hedges as defined by Statement of Financial Accounting Standards No. 133, “Accounting for Derivative Instruments and Hedging Activities,” as amended (“SFAS No. 133”). These judgments and analyses include an assessment that the derivative instruments used are effective hedges of the underlying risks. If the Company were to fail to meet the requirements of SFAS No. 133, or if these derivative instruments are not designated as hedges, the Company would be required to mark these contracts to market at each reporting date. Penford had deferred losses, net of tax, of $0.5 million at November 30, 2007, which are reflected in accumulated other comprehensive income.
     Benefit Plans
     Penford has defined benefit plans for its U.S. employees providing retirement benefits and coverage for retiree health care. Qualified third-party actuaries assist management in determining the expense and funded status of these employee benefit plans. Management makes several estimates and assumptions in order to measure the expense and funded status, including interest rates used to discount certain liabilities, rates of return on plan assets, rates of compensation increases, employee turnover rates, anticipated mortality rates, and increases in the cost of medical care. The Company makes judgments about these assumptions based on historical investment results and experience as well as available historical market data and trends. However, if these assumptions are wrong, it could materially affect the amounts reported in the Company’s future results of operations.
     Valuation of Goodwill
     Penford is required to assess, on an annual basis, whether the value of goodwill reported on the balance sheet has been impaired, or more often if conditions exist that indicate that there might be an impairment. These assessments require extensive and subjective judgments to assess the fair value of goodwill. While the Company engages qualified valuation experts to assist in this process, their work is based on the Company’s estimates of future operating results and allocation of goodwill to the business units. If future operating results differ materially from the estimates, the value of goodwill could be adversely impacted.
      Self-insurance Program
     The Company maintains a self-insurance program covering portions of workers’ compensation and group health liability costs. The amounts in excess of the self-insured levels are fully insured by third-party insurers. Liabilities associated with these risks are estimated in part by considering historical claims experience, severity factors and other actuarial assumptions. Projections of future losses are inherently uncertain because of the random nature of insurance claims occurrences and changes that could occur in actuarial assumptions. The financial results of the Company could be significantly affected if future claims and assumptions differ from those used in determining these liabilities.
     Income Taxes
     The determination of the Company’s provision for income taxes requires significant judgment, the use of estimates and the interpretation and application of complex tax laws. The Company’s provision for income taxes reflects a combination of income earned and taxed in the various U.S. federal and state, as well as Australian and New Zealand, taxing jurisdictions. Jurisdictional tax law changes, increases or decreases in permanent differences between book and tax items, valuation allowances, and the Company’s change in the mix of earnings from these taxing jurisdictions all affect the overall effective tax rate.
     Effective September 1, 2007, the Company adopted FIN 48. See discussion in Note 7 to the Condensed Consolidated Financial Statements. The calculation of tax liabilities involves dealing with uncertainties in the application of complex tax regulations. As a result of the implementation of FIN 48, the Company recognizes liabilities for uncertain tax positions based on the two-step process prescribed with the interpretation. The first step

23


Table of Contents

is to evaluate the tax position for recognition by determining if the available evidence indicates that it is more likely than not that the position will be sustained on audit, including related appeals or litigation. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate settlement. It is inherently difficult and subjective to estimate such amounts, as this requires management to determine the probability of various possible outcomes. The Company evaluates these uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, changes in facts and circumstances, changes in tax law, effectively settled audit issues and new audit activity. Such changes in recognition or measurement would result in the recognition of a tax benefit or an additional charge to the tax provision in the period.
     Stock-Based Compensation
     The Company recognizes stock-based compensation in accordance with SFAS No. 123R. Under the fair value recognition provisions of this statement, share-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the award. Determining the appropriate fair value model and calculating the fair value of the share-based awards at the date of grant requires judgment, including estimating stock price volatility, forfeiture rates, the risk-free interest rate, dividends and expected option life. See Note 3 to the Condensed Consolidated Financial Statements.
     If circumstances change, and the Company uses different assumptions for volatility, interest, dividends and option life in estimating the fair value of stock-based awards granted in future periods, stock-based compensation expense may differ significantly from the expense recorded in the current period. SFAS No. 123R requires forfeitures to be estimated at the date of grant and revised in subsequent periods if actual forfeitures differ from those estimated. Therefore, if actual forfeiture rates differ significantly from those estimated, the Company’s results of operations could be materially impacted.
     Item 3: Quantitative and Qualitative Disclosures About Market Risk.
     The Company is exposed to market risks from adverse changes in interest rates, foreign currency exchange rates and commodity prices. There have been no material changes in the Company’s exposure to market risks since August 31, 2007.
     Item 4: Controls and Procedures.
     Evaluation of Disclosure Controls and Procedures
     Penford’s management, with the participation of its chief executive officer and chief financial officer, evaluated the effectiveness of the Company’s disclosure controls and procedures as of November 30, 2007. Based on management’s evaluation, the chief executive officer and chief financial officer have concluded that the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are effective to ensure that information required to be disclosed by the Company in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and is accumulated and communicated to management, including the chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.
     Changes in Internal Control over Financial Reporting
     There was no change in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended November 30, 2007 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

24


Table of Contents

PART II — OTHER INFORMATION
     Item 1: Legal Proceedings
     In October 2004, Penford Products Co. (“Penford Products”), a wholly-owned subsidiary of the Company, was sued by Graphic Packaging International, Inc. (“Graphic”) in the Fourth Judicial District Court, Ouachita Parish, Louisiana. Graphic sought monetary damages for Penford Products’ alleged breach of an agreement during the 2004 strike affecting its Cedar Rapids, Iowa plant to supply Graphic with certain starch products. Penford Products denied all liability and countersued for damages.
     During October 2007, this case was tried before a judge of the above-noted court. As of January 8, 2008, the court had not advised Penford Products of a decision in the matter or the date upon which a decision would be rendered. At trial, Graphic argued that it was entitled to damages in the amount of approximately $3.27 million, plus interest. Penford Products argued that it was entitled to damages of approximately $550,000, plus interest.
     While the Company vigorously defended its position at trial, it has, after applying its best judgment regarding the likely outcome of the litigation, established a loss contingency against this matter of $2.4 million. Depending upon the eventual outcome of this litigation, the Company may incur additional material charges in excess of the amount it has reserved, or it may incur lower charges, the amounts of which in each case management is unable to predict at this time.
     The Company is involved from time to time in various other claims and litigation arising in the normal course of business. In the judgment of management, which relies in part on information from the Company’s outside legal counsel, the ultimate resolution of these matters will not materially affect the consolidated financial position, results of operations or liquidity of the Company.
      Item 1A: Risk Factors
     The information set forth in this report should be read in conjunction with the risk factors discussed in Item 1A of the Company’s Annual Report on Form 10-K for the year ended August 31, 2007, which could materially impact the Company’s business, financial condition and future results. The risks described in the Annual Report on Form 10-K are not the only risks facing the Company. Additional risks and uncertainties not currently known by the Company or that the Company currently deems to be immaterial also may materially adversely affect the Company’s business, financial condition and/or operating results.
      Item 6: Exhibits.
     (d) Exhibits
     
31.1
  Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
   
31.2
  Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
   
32
  Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

25


Table of Contents

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
         
     
  Penford Corporation    
  (Registrant)   
     
     
January 9, 2008  /s/ Steven O. Cordier    
  Steven O. Cordier   
  Senior Vice President and Chief Financial Officer   

26


Table of Contents

EXHIBIT INDEX
     
Exhibit No.   Description
 
   
31.1
  Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
   
31.2
  Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
   
32
  Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002